Regenxbio Inc (RGNX)

12:54 PM

Price momentum metrics for REGENXBIO Inc. explainedWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com

12:54 PM

Oct 15, 2025

Why REGENXBIO Inc. stock appeals to dividend seekersBreakout Watch & Advanced Swing Trade Entry Plans - newser.com

Oct 15, 2025

Oct 15, 2025

Why REGENXBIO Inc. stock is considered a top pickWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Oct–Nov 2025: REGENXBIO to Present at Chardan, Guggenheim & Stifel Conferences; webcasts available for 30 days - Stock Titan

Oct 15, 2025

Oct 15, 2025

Automated trading signals detected on REGENXBIO Inc.Entry Point & AI Driven Stock Reports - newser.com

Oct 15, 2025

Oct 15, 2025

Will REGENXBIO Inc. stock go up soonJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com

Oct 15, 2025

Oct 14, 2025

What does recent volatility data suggest for REGENXBIO Inc.2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com

Oct 14, 2025

Oct 14, 2025

REGENXBIO Inc Stock Analysis and ForecastSwing Trading Ideas & Rapid Capital Gain - earlytimes.in

Oct 14, 2025

Oct 13, 2025

Gene Therapy in Ophthalmology Market Revenue to Expand Significantly by 2034, States DelveInsight Report | REGENXBIO, GenSight Biologics, Neurophth Therapeutics - Barchart.com

Oct 13, 2025

Oct 13, 2025

How to build a dashboard for REGENXBIO Inc. stockTrade Entry Report & Safe Capital Growth Plans - newser.com

Oct 13, 2025

Oct 12, 2025

Using data filters to optimize entry into REGENXBIO Inc.Analyst Upgrade & Weekly Return Optimization Plans - newser.com

Oct 12, 2025

Oct 12, 2025

Market reaction to REGENXBIO Inc.’s recent newsQuarterly Trade Report & Expert Verified Stock Movement Alerts - newser.com

Oct 12, 2025

Oct 11, 2025

REGENXBIO (NASDAQ:RGNX) CEO Curran Simpson Sells 20,811 Shares - MarketBeat

Oct 11, 2025

Oct 10, 2025

Insider Sell: Curran Simpson Sells Shares of Regenxbio Inc (RGNX) - GuruFocus

Oct 10, 2025

Oct 10, 2025

Regenxbio CEO Simpson Curran sells $262,634 in stock By Investing.com - Investing.com South Africa

Oct 10, 2025

Oct 10, 2025

Regenxbio CEO Simpson Curran sells $262,634 in stock - Investing.com

Oct 10, 2025

Oct 10, 2025

Chart based analysis of REGENXBIO Inc. trendsWeekly Trade Summary & Safe Entry Momentum Tips - newser.com

Oct 10, 2025

Oct 10, 2025

REGENXBIO (NASDAQ:RGNX) Reaches New 12-Month HighTime to Buy? - MarketBeat

Oct 10, 2025

Oct 10, 2025

REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual Meeting - Eastern Progress

Oct 10, 2025

Oct 10, 2025

Why REGENXBIO Inc. is moving todayWeekly Profit Report & Long-Term Safe Return Strategies - newser.com

Oct 10, 2025

Oct 10, 2025

Weiss Ratings Reiterates "Sell (D-)" Rating for REGENXBIO (NASDAQ:RGNX) - MarketBeat

Oct 10, 2025

Oct 10, 2025

Is REGENXBIO Inc. trending in predictive chart modelsJuly 2025 Big Picture & Smart Allocation Stock Tips - newser.com

Oct 10, 2025

Oct 10, 2025

How cyclical is REGENXBIO Inc. (RB0) stock compared to rivalsJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com

Oct 10, 2025

Oct 09, 2025

REGENXBIO, Inc. Hits New 52-Week High at $12.30 - Markets Mojo

Oct 09, 2025

Oct 09, 2025

2-Year Results: REGENXBIO Presents ALTITUDE Phase II Data for Diabetic Retinopathy Oct 17 - Stock Titan

Oct 09, 2025

Oct 09, 2025

REGENXBIO Inc. (NASDAQ:RGNX) Held Back By Insufficient Growth Even After Shares Climb 29% - simplywall.st

Oct 09, 2025

Oct 09, 2025

Is REGENXBIO Inc. stock positioned for digital transformationTrade Risk Report & Reliable Entry Point Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Is REGENXBIO Inc. (RB0) stock a top hedge fund pickTrade Risk Assessment & Free High Return Stock Watch Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

REGENXBIO (NASDAQ:RGNX) Trading 9.1% HigherShould You Buy? - MarketBeat

Oct 08, 2025

Oct 08, 2025

REGENXBIO Inc. (NASDAQ:RGNX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 08, 2025

Oct 07, 2025

REGENXBIO's (RGNX) "Buy" Rating Reiterated at HC Wainwright - MarketBeat

Oct 07, 2025

Oct 07, 2025

HC Wainwright & Co. Reiterates REGENXBIO (RGNX) Buy Recommendation - Nasdaq

Oct 07, 2025

Oct 07, 2025

Regenxbio stock maintains Buy rating at H.C. Wainwright on gene therapy potential - Investing.com

Oct 07, 2025

Oct 07, 2025

HC Wainwright & Co. Reiterates Buy Rating for RGNX with $34 Targ - GuruFocus

Oct 07, 2025

Oct 06, 2025

Viral Vector Gene Therapy Market Size Expects to Reach USD 38.39 Billion by 2034 - GlobeNewswire Inc.

Oct 06, 2025

Oct 06, 2025

Regenxbio Inc. Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet Amd - MarketScreener

Oct 06, 2025

Oct 06, 2025

REGENXBIO completes enrollment in wet AMD gene therapy trials - Investing.com

Oct 06, 2025

Oct 06, 2025

RGNX Completes Enrollment for Key Macular Degeneration Studies - GuruFocus

Oct 06, 2025

Oct 06, 2025

REGENXBIO completes enrollment in wet AMD gene therapy trials By Investing.com - Investing.com Nigeria

Oct 06, 2025

Oct 06, 2025

Regenxbio announces completion of enrollment in pivotal trials of subretinal surabgene lomparvovec for wet AMD - MarketScreener

Oct 06, 2025

Oct 06, 2025

Regenxbio announces completion of enrollment in pivotal trials of subretinal surabgene lomparvovec for WET AMD - TradingView

Oct 06, 2025

Oct 06, 2025

1,200+ Enrolled: REGENXBIO Completes Largest Gene Therapy Wet AMD Program; Topline Q4 2026 - Stock Titan

Oct 06, 2025

Oct 06, 2025

What indicators show strength in REGENXBIO Inc.2025 Trading Recap & Low Risk High Win Rate Picks - newser.com

Oct 06, 2025

Oct 05, 2025

Combining price and volume data for REGENXBIO Inc.2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com

Oct 05, 2025

Oct 05, 2025

Will REGENXBIO Inc. stock gain from lower inflation2025 Performance Recap & Technical Pattern Based Signals - newser.com

Oct 05, 2025